WindRose Health Investors Named to HEC-DowJones List of Top 20 Upper MidMarket PE Firms

WindRose & Portfolio Company News

New York, NY, March 4, 2026 – WindRose Health Investors announced today that it has been recognized as a top performer in the 2025 HEC-DowJones Upper MidMarket Buyout Performance Ranking Report. The ranking lists the world’s top 20 firms in terms of aggregate performance based on all buyout funds raised between 2012 and 2021.

The ranking analyzes aggregate performance data from Preqin and direct disclosures from PE firms. By utilizing a proprietary methodology developed by HEC Paris, the report identifies firms generating the best aggregate performance for investors over the past decade.

“We are honored to be recognized among the world’s top performers in the 2025 HEC-DowJones Upper MidMarket Buyout Performance Ranking,” said Oliver T. Moses, WindRose’s Managing Partner. “This inclusion is a testament to the discipline of our investment strategy and our team’s dedication to building enduring value. We are grateful for the continued trust of our investors and the hard work of the management teams we partner with, whose collaboration is central to these results.”

WindRose ranked number 18 in the report, which was issued by HEC Paris, a premier global business school, in partnership with Private Equity News, a specialized DowJones publication.

This ranking is the opinion of the party conferring the ranking and not of WindRose Health Investors. The 2025 HEC-DowJones Upper MidMarket Buyout Performance Ranking Report, published on March 3, 2026, was based on funds raised between 2012 and 2021. WindRose Health Investors did not pay to receive this recognition. There can be no assurance that other providers or surveys would reach the same conclusion as the foregoing.

About WindRose Health Investors

New York City-based WindRose makes equity investments in companies that operate within the services sectors of the healthcare industry. The firm focuses on companies with profitable business models and a demonstrated ability to deliver cost-effective solutions. With approximately $7 billion under management, WindRose invests in companies throughout the United States. For more information, please email us at info@windrose.com.